ArticleAdvances in urology2025
The Impact of IncontiLase Er:YAG Laser Treatment on the Quality of Life of Women With Stress Urinary Incontinence.
Article in Advances in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Impact of IncontiLase Er:YAG Laser Treatment on the Quality of Life of Women With Stress Urinary Incontinence.Advances in urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Assessment of health-related quality of life (QoL) is particularly crucial in urinary incontinence because this condition significantly affects patients' social, psychological, physical, emotional, and economic wellbeing. The objective of this service evaluation was to assess various QoL outcomes in patients with stress urinary incontinence (SUI) before and after treatment with a nonablative Er:YAG laser. Methods: Upon receiving SUI laser treatment (IncontiLase) at our clinic, 49 patients subsequently provided follow-up assessments of health-related QoL outcome measures at two time points (2-month FU (FU1) and 9-month FU (FU2)). Results: Prior to treatment, patients were strongly bothered by their SUI symptoms. Two months after treatment, all the patients reported significant improvements of SUI symptoms and SUI-related QoL, which continued to improve with time. According to the QoL scores, patients did not consider their SUI symptoms bothersome enough to seek further medical care after laser treatment, even after a period of 9 months. Conclusions: Nonablative Er:YAG laser treatment was associated with substantial, clinically meaningful improvements in patient-reported SUI-related QoL in a real-world clinical setting. This service evaluation supports the use of Er:YAG laser treatment in clinical practice, although the study design limits the strength of conclusions regarding its effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.